Antineoplaston plus radiation versus radiation alone for brainstem glioma
Part of Brain & nervous system, Cancer clinical trials.
This trial studies whether adding antineoplaston therapy to standard radiation works better than radiation alone for children and adults with a specific type of brainstem glioma. It aims to improve tumor control while comparing side effects between the two approaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diffuse, intrinsic brainstem glioma in the pons area that shows a specific MRI pattern and involves more than half of the pons
- Your tumor type is confirmed by pathology (or, if less than half the pons is involved, it must match certain cancer types such as anaplastic glioma or glioblastoma)
- You can get a baseline MRI within 14 days before starting antineoplaston, with the required scan types done at an accredited center
- You are able to take steroids at a fixed dose for at least 5 days before the baseline MRI (and you may need a new MRI if the dose changes)
- Age and function limits apply: you must be at least 3 years old, and your performance level must be above a certain threshold for your age group
- Your blood tests and organ health must be strong enough (for example, certain minimum blood counts and liver/kidney numbers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies whether antineoplaston therapy changes the heart’s electrical timing (the QT/QTc interval) in people with diffuse intrinsic brainstem glioma. It may be helpful if you’re being evaluated for this specific treatment approach and safety monitoring.
This trial tests a new combination treatment for children and young adults with brain tumors that have come back or not responded to standard therapy. The treatment includes a gene therapy (SGT-53) that delivers a normal TP53 gene, a checkpoint inhibitor drug that helps the immune system attack the cancer, and focused radiation. The goal is to see if this combination is safe and can shrink tumors.
This trial tests whether adding sonodynamic therapy (a treatment that uses sound waves to activate a drug) before standard radiation and chemotherapy can help people with a type of brainstem glioma called DIPG. The goal is to see if this combination improves survival.
This trial tests adding atovaquone to standard radiation therapy for children with aggressive brain tumors like high-grade glioma (a fast-growing brain cancer) or medulloblastoma. The goal is to see if this drug, which targets energy production in cancer cells, can make radiation work better.
This trial tests a type of radiation (protons) for brain tumors called atypical or anaplastic meningiomas that need radiotherapy. It may help by aiming radiation more precisely while also learning the safest and most effective dose.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
Hear when a new Brain Stem Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.